EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma

Alexander W Loftus, Mehrdad Zarei, Hanna Kakish, Omid Hajihassani, Jonathan J Hue, Christina Boutros, Hallie J Graor, Faith Nakazzi, Tsegaw Bahlibi, Jordan M Winter, Luke D Rothermel

Cancer Treatment Reviews · 2024-09 · 129 · 102795

DOI: 10.1016/j.ctrv.2024.102795 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2024-09. Verfasst von Alexander W Loftus und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, 11100 Euclid Ave., Cleveland, OH 44106, USA. Hauptthemen laut MEDLINE: Melanoma, Proto-Oncogene Proteins B-raf. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 116 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: FIC NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma metabolism can be reprogrammed by activating BRAF mutations. These mutations are present in up to 50% of cutaneous melanomas, with the most common being V600E. BRAF mutations augment glycolysis to promote macromolecular synthesis and proliferation. Prior to the development of targeted anti-BRAF therapies, these mutations were associated with accelerated clinical disease in the metastatic setting. Combination BRAF and MEK inhibition is a first line treatment option for locally advanced or metastatic melanoma harboring targetable BRAF mutations. This therapy shows excellent response rates but these responses are not durable, with almost all patients developing resistance. When BRAF mutated melanoma cells are inhibited with targeted therapies the metabolism of those cells also changes. These cells rely less on glycolysis for energy production, and instead shift to a mitochondrial phenotype with upregulated TCA cycle activity and oxidative phosphorylation. An increased dependence on glutamine utilization is exhibited to support TCA cycle substrates in this metabolic rewiring of BRAF mutated melanoma. Herein we describe the relevant core metabolic pathways modulated by BRAF inhibition. These adaptive pathways represent vulnerabilities that could be targeted to overcome resistance to BRAF inhibitors. This review evaluates current and future therapeutic strategies that target metabolic reprogramming in melanoma cells, particularly in response to BRAF inhibition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaProto-Oncogene Proteins B-rafHumansProtein Kinase InhibitorsMutationSkin NeoplasmsGlycolysis

Stichwörter der Autor:innen

Amino acidBRAFFatty acidGlycolysisMelanomaMetabolic reprogrammingMitochondriaNovel therapiesOxidative phosphorylationResistanceTargeted therapies

Substanzen

Proto-Oncogene Proteins B-rafBRAF protein, humanProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, 11100 Euclid Ave., Cleveland, OH 44106, USA.
  • Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH, USA.
  • Department of Surgery, Division of Surgical Oncology, University Hospitals Cleveland Medical Center, 11100 Euclid Ave., Cleveland, OH 44106, USA; Case Comprehensive Cancer Center, Case Western Reserve University, Clevel…

Förderung

  • FIC NIH HHS
  • NCI NIH HHS

Zitieren

APA

Loftus, A. W., Zarei, M., Kakish, H., Hajihassani, O., Hue, J. J., Boutros, C., Graor, H. J., Nakazzi, F., Bahlibi, T., Winter, J. M., & Rothermel, L. D. (2024). Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma. Cancer Treatment Reviews, 129, 102795. https://doi.org/10.1016/j.ctrv.2024.102795

Vancouver

Loftus AW, Zarei M, Kakish H, Hajihassani O, Hue JJ, Boutros C, et al. Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma. Cancer Treatment Reviews. 2024;129:102795. doi:10.1016/j.ctrv.2024.102795

BibTeX
@article{Loftus2024,
  author = {Loftus, Alexander W and Zarei, Mehrdad and Kakish, Hanna and Hajihassani, Omid and Hue, Jonathan J and Boutros, Christina and Graor, Hallie J and Nakazzi, Faith and Bahlibi, Tsegaw and Winter, Jordan M and Rothermel, Luke D},
  title = {Therapeutic implications of the metabolic changes associated with BRAF inhibition in melanoma},
  journal = {Cancer Treatment Reviews},
  year = {2024},
  volume = {129},
  pages = {102795},
  doi = {10.1016/j.ctrv.2024.102795}
}
Kostenlos starten →